|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluoroura- cil for coloreetal cancer liver metastases 显示文摘 | Neyns B Van Nieuwenhove Y Aerts M | 2006 | Anticancer Res2006，26，1： | 1 |
| 2 | Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma 显示文摘 | Stupp R Hegi ME Neyns B | 2010 | J Clin Oncol2010，28，16： | 1 |
| 3 | The role of cytotoxic drugs in the treatment of central nervous system gliomas 显示文摘 | Neyns B D'Haeseleer M Rogiers A | 2010 | Acta Neurol Belg2010，110，1： | 1 |
| 4 | Stratified phase Ⅱ trial of cetuximab in patients with recurrent high-grade glioma显示文摘 | Neyns B Sadones J Joosens E | 2009 | Ann Oncol2009，20，： | 1 |
| 5 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double - blind, multicentre, phase 2, dose - ranging study显示文摘 | WOLCHOK J D NEYNS B LINETYE G | 2010 | Lancet Oneol2010，11，2： | 1 |
| 6 | Ipilimumab monotherapy in patients with pretreated advanced melanoma:a randomised,double-blind,muhicentre,phase 2, dose-ranging study显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oneol2010，11，2： | 1 |
| 7 | Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma显示文摘 | Stupp R Hegi ME Neyns B | 2010 | J Clin Oncol2010，28，16： | 1 |
| 8 | Activity of sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers显示文摘 | Decoster L Neyns B Vande Brock I | | 0，，15： | 1 |
| 9 | A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC)显示文摘 | Schallier D Neyns B Fontaine C | 2007 | Lung Cancer2007，56，24： | 1 |
| 10 | Phase HI randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma显示文摘 | Batchelor TT Mulholland P Neyns B | 2013 | J Clin Oneol2013，31，： | 1 |
| 11 | Lpilimumab monotherapy in patients with pretreated advanced melanoma:a randomised,double-blind,multicentre,phase 2,dose-ranging study显示文摘 | Wolchok J Neyns B Linette G | | 0，，： | 1 |
| 12 | Ipilimumab monother- apy in patients with pretreated advanced melanoma: a ran- domised, double-blind, multicentre, phase 2, dose-ranging study 显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 13 | Pseudoprogression after radiot herapy with concurrent temozolomide for high-grade glioma:clinical observations and working recommendations显示文摘 | Chaskis C Neyns B Michotte A | 2009 | Surg Neurol2009，72，4： | 1 |
| 14 | A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer(NSCLC) 显示文摘 | Schallier D Neyns B Fontaine C | 2007 | Lung Cancer2007，56，2： | 1 |
| 15 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, muhieentre, phase 2 ,dose-ranging study 显示文摘 | Wolehok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，2： | 1 |
| 16 | Phase Ⅱ study of sunitinib malate in patients with recurrent high-grade glioma 显示文摘 | Neyns B Sadones J Chaskis C et ol | 2011 | J Neurooncol2011，103，3： | 1 |
| 17 | Dose-dense temozolo- mide regimens: antitumor activity, toxicity, and immunomod- ulatory effects显示文摘 | Neyns B Tosoni A Hwu WJ | 2010 | Cancer2010，116，12： | 1 |
| 18 | lpilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double - blind, muhicentre, phase 2, dose - ranging study 显示文摘 | Wolchok JD Neyns B Linette G | 2010 | Lancet Oncol2010，11，： | 1 |
| 19 | Efficacy of infusionalbiomodulated 5-fluorouracil in metastatic colorectal cancer afterraltitrexed failure显示文摘 | Decoster L Neyns B Akouaouach H | 2004 | Anticancer Res2004，24，： | 1 |
| 20 | Exploiting dendritic cells for cancer immunotherapy:genetic modification of dendritic cells显示文摘 | Breckpot K Heiman C Neyns B | 2004 | J Gene Med2004，6，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员